Gibson Christopher - Insider Stock Trading

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
4/5/24 17:44	4/3/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-1,161	8.93	-130	-12	939	M
4/1/24 18:40	3/28/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-657	10.10	-65	-6	1,044	M
3/8/24 19:08	3/6/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-720	11.73	-61	-5	1,109	M
3/8/24 19:08	3/6/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	176	4.42	40	4	1,109	M
2/9/24 17:34	2/7/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-445	9.22	-48	-6	775	D
2/9/24 17:34	2/7/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	775	D
1/5/24 20:03	1/3/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	792	M
1/5/24 20:03	1/3/24	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-531	9.50	-56	-7	792	M
12/8/23 17:22	12/6/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-448	7.49	-60	-7	791	D
12/8/23 17:22	12/6/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	791	D
11/3/23 18:14	11/1/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-321	5.17	-62	-7	837	M
11/3/23 18:14	11/1/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	837	M
10/6/23 18:12	10/4/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-431	7.21	-60	-7	843	D
10/6/23 18:12	10/4/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	843	D
9/8/23 17:01	9/6/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-517	8.81	-59	-6	871	M
9/8/23 17:01	9/6/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	871	M
8/4/23 17:51	8/2/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	176	4.42	40	5	891	D
8/4/23 17:51	8/2/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-848	13.04	-65	-7	891	D
7/14/23 18:52	7/12/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-712	12.54	-57	-6	916	M
7/14/23 18:52	7/12/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	916	M
6/9/23 17:12	6/7/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-511	9.05	-56	-6	916	D
6/9/23 17:12	6/7/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	916	D
5/5/23 18:44	5/3/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-278	4.79	-58	-6	953	M
5/5/23 18:44	5/3/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	3	953	M
4/28/23 16:32	1/5/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.ad	-137	7.39	-19	-3	583	D
4/7/23 17:30	4/5/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-352	6.60	-53	-6	907	D
4/7/23 17:30	4/5/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	4	907	D
3/10/23 17:34	3/8/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-893	8.05	-111	-11	939	M
3/10/23 17:34	3/8/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	233	2.48	94	11	939	M
3/6/23 18:07	3/2/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-166	7.92	-21	-2	941	M
2/3/23 17:11	2/2/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-194	9.22	-21	-2	942	M
1/6/23 18:28	1/5/23	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-155	7.39	-21	-4	526	M
12/2/22 18:17	12/1/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-359	9.04	-40	-6	583	M
12/2/22 18:17	12/1/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	6	583	M
11/4/22 18:39	11/3/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	6	576	M
11/4/22 18:39	11/3/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-392	10.01	-39	-6	576	M
10/7/22 19:19	10/6/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-447	11.58	-39	-6	563	M
10/7/22 19:19	10/6/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	6	563	M
9/2/22 19:24	9/1/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-404	10.35	-39	-7	549	M
9/2/22 19:24	9/1/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	6	549	M
8/5/22 19:34	8/4/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-373	9.49	-39	-7	542	M
8/5/22 19:34	8/4/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	6	542	M
7/8/22 18:36	7/7/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-359	9.05	-40	-7	529	M
7/8/22 18:36	7/7/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	6	529	M
6/6/22 20:54	6/2/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	6	516	M
6/6/22 20:54	6/2/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-258	6.11	-42	-8	516	M
5/6/22 20:13	5/4/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-358	6.47	-55	-10	512	M
5/6/22 20:13	5/4/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	78	2.48	31	7	512	M
5/2/22 21:30	4/28/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-495	6.14	-81	-14	494	M
5/2/22 21:30	4/28/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.dm	218	2.48	88	22	494	M
4/25/22 21:26	4/21/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-494	6.17	-80	-15	445	M
4/25/22 21:26	4/21/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.dm	218	2.48	88	25	445	M
4/20/22 21:03	4/18/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-262	6.83	-38	-9	395	M
4/20/22 21:03	4/18/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	109	2.48	44	13	395	M
4/18/22 21:46	4/14/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-280	7.55	-37	-9	368	M
4/18/22 21:46	4/14/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	109	2.48	44	14	368	M
4/12/22 20:05	4/8/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-260	6.60	-39	-10	340	M
4/12/22 20:05	4/8/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	109	2.48	44	15	340	M
4/11/22 20:54	4/7/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-257	6.54	-39	-11	315	M
4/11/22 20:54	4/7/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	109	2.48	44	16	315	M
4/8/22 19:03	4/6/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-259	6.76	-38	-12	289	M
4/8/22 19:03	4/6/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	109	2.48	44	18	289	M
4/7/22 21:15	4/5/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-275	7.43	-37	-12	262	M
4/7/22 21:15	4/5/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	109	2.48	44	20	262	M
3/15/22 20:57	3/11/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-2,177	6.48	-336	-59	234	D
3/9/22 20:44	3/7/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-2,189	7.30	-300	-56	234	D
2/24/22 19:24	2/22/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-1,022	10.22	-100	-30	234	D
2/2/22 20:09	1/31/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-233	11.73	-20	-46	23	D
1/14/22 20:42	1/13/22	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-4,692	13.76	-341	-94	23	D
12/20/21 17:59	12/16/21	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-4	20.01	0	-1	23	D
12/15/21 20:01	12/13/21	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.d	-2	20.02	0	0	23	D
12/10/21 21:42	12/8/21	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S.dm	-237	20.13	-12	-33	23	D
12/10/21 21:42	12/8/21	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	M.d	71	2.47	29		23	D
12/9/21 21:52	12/7/21	RXRX	Recursion Pharmaceuticals, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Gibson Christopher	UT	DO	CEO	S	-405	20.48	-20	0	9,448	M

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y